-SEC Filing
Goldman Sachs Downgrades Nuvei to Neutral, Lowers Price Target to $40
Goldman Sachs analyst Will Nance downgrades Nuvei (NASDAQ:NVEI) from Buy to Neutral and lowers the price target from $72 to $40.
Related Posts
Piper Sandler Initiates Coverage On Blend Labs with Overweight Rating, Announces Price Target of $24
Piper Sandler analyst Justin Patterson initiates coverage on Blend Labs (NYSE:BLND) with a Overweight rating and announces Price Target of $24.
Elon Musk’s Name Used With Verified Twitter Profile Of Hacked Indonesian Consulate To Dupe Unsuspecting Users Of Bitcoin
Scammers pretending to be Tesla Inc (NASDAQ: TSLA) CEO Elon Musk appear to have taken over a Twitter account belonging to the Consulate General of Indonesia in Kota Kinabalu, Malaysia.
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
Developmental-stage psychedelics biotech company Silo Pharma Inc. (NASDAQ: SILO) has begu